Exact Mass: 1174.5043222
Exact Mass Matches: 1174.5043222
Found 11 metabolites which its exact mass value is equals to given mass value 1174.5043222,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Carboxyyessotoxin
(3E)-5-Hydroxy-5-[34-hydroxy-13,25,27,30,35-pentamethyl-39-methylidene-14-(sulphooxy)-13-[2-(sulphooxy)ethyl]-4,8,12,17,21,26,32,36,41,45,49-undecaoxaundecacyclo[25.22.0.0³,²⁵.0⁵,²².0⁷,²⁰.0⁹,¹⁸.0¹¹,¹⁶.0³¹,⁴⁸.0³³,⁴⁶.0³⁵,⁴⁴.0³⁷,⁴²]nonatetracontan-40-yl]-2-(prop-2-en-1-yl)hex-3-enoic acid
Carboxyyessotoxin is found in mollusks. Carboxyyessotoxin is a constituent of the mussel Mytilus galloprovincialis.
3-((3-Malonyl)GlcA)-28-Xyl(1-4)Rha(1-2)Ara Medicagenic acid
3-((3-Malonyl)GlcA)-28-Xyl(1-4)Rha(1-2)Ara Medicagenic acid
Carboxyyessotoxin
(3E)-5-hydroxy-5-[34-hydroxy-13,25,27,30,35-pentamethyl-39-methylidene-14-(sulfooxy)-13-[2-(sulfooxy)ethyl]-4,8,12,17,21,26,32,36,41,45,49-undecaoxaundecacyclo[25.22.0.0^{3,25}.0^{5,22}.0^{7,20}.0^{9,18}.0^{11,16}.0^{31,48}.0^{33,46}.0^{35,44}.0^{37,42}]nonatetracontan-40-yl]-2-(prop-2-en-1-yl)hex-3-enoic acid
n,n-diphenyl-n,n-bis(4-(n,n-bis(naphth-1-yl)-amino)-biphenyl-4-yl)-benzidine
n,n-diphenyl-n,n-bis(4-(n,n-bis(naphth-1-yl)-amino)-biphenyl-4-yl)-benzidine
PRL 2915
PRL 2915
C59H71ClN12O8S2 (1174.4647516)
PRL 2915 is a potent human somatostatin subtype 2 receptor (hsst2) antagonist with a Ki of 12 nM[1].
n-(6-{1,2-dihydroxy-2-[4-hydroxy-3-(sulfooxy)phenyl]ethyl}-5,8,11,17,20,21,23,25-octahydroxy-3-[1-hydroxy-2-(c-hydroxycarbonimidoyl)ethyl]-15-(1-hydroxyethyl)-26-methyl-2,14-dioxo-1,4,7,13,16,22-hexaazatricyclo[22.3.0.0⁹,¹³]heptacosa-4,7,16,22-tetraen-18-yl)hexadecanimidic acid
n-(6-{1,2-dihydroxy-2-[4-hydroxy-3-(sulfooxy)phenyl]ethyl}-5,8,11,17,20,21,23,25-octahydroxy-3-[1-hydroxy-2-(c-hydroxycarbonimidoyl)ethyl]-15-(1-hydroxyethyl)-26-methyl-2,14-dioxo-1,4,7,13,16,22-hexaazatricyclo[22.3.0.0⁹,¹³]heptacosa-4,7,16,22-tetraen-18-yl)hexadecanimidic acid
n-(6-{1,2-dihydroxy-2-[4-hydroxy-3-(sulfooxy)phenyl]ethyl}-5,8,11,17,20,21,23,25-octahydroxy-3-[1-hydroxy-2-(c-hydroxycarbonimidoyl)ethyl]-15-(1-hydroxyethyl)-26-methyl-2,14-dioxo-1,4,7,13,16,22-hexaazatricyclo[22.3.0.0⁹,¹³]heptacosa-4,7,16,22-tetraen-18-yl)-10,12-dimethyltetradecanimidic acid
n-(6-{1,2-dihydroxy-2-[4-hydroxy-3-(sulfooxy)phenyl]ethyl}-5,8,11,17,20,21,23,25-octahydroxy-3-[1-hydroxy-2-(c-hydroxycarbonimidoyl)ethyl]-15-(1-hydroxyethyl)-26-methyl-2,14-dioxo-1,4,7,13,16,22-hexaazatricyclo[22.3.0.0⁹,¹³]heptacosa-4,7,16,22-tetraen-18-yl)-10,12-dimethyltetradecanimidic acid
(10r,12s)-n-[(3s,6s,9r,11s,15r,18r,20r,21s,24r,25s,26r)-6-[(1s,2r)-1,2-dihydroxy-2-[4-hydroxy-3-(sulfooxy)phenyl]ethyl]-5,8,11,17,20,21,23,25-octahydroxy-3-[(1r)-1-hydroxy-2-(c-hydroxycarbonimidoyl)ethyl]-15-[(1s)-1-hydroxyethyl]-26-methyl-2,14-dioxo-1,4,7,13,16,22-hexaazatricyclo[22.3.0.0⁹,¹³]heptacosa-4,7,16,22-tetraen-18-yl]-10,12-dimethyltetradecanimidic acid
(10r,12s)-n-[(3s,6s,9r,11s,15r,18r,20r,21s,24r,25s,26r)-6-[(1s,2r)-1,2-dihydroxy-2-[4-hydroxy-3-(sulfooxy)phenyl]ethyl]-5,8,11,17,20,21,23,25-octahydroxy-3-[(1r)-1-hydroxy-2-(c-hydroxycarbonimidoyl)ethyl]-15-[(1s)-1-hydroxyethyl]-26-methyl-2,14-dioxo-1,4,7,13,16,22-hexaazatricyclo[22.3.0.0⁹,¹³]heptacosa-4,7,16,22-tetraen-18-yl]-10,12-dimethyltetradecanimidic acid